BioTech
-
Sanofi strikes deal with Novavax, boosting the vaccine maker
LONDON — Novavax, the beleaguered maker of a Covid-19 vaccine, just got a boost of its own. The French pharma…
Read More » -
Exact Sciences stock tumbles despite strong cancer detection sales
Exact Sciences reported first-quarter revenues this week that beat market expectations, and the cancer detection company’s executives still believe they’re…
Read More » -
Jennifer Adair on making gene therapy available globally
BALTIMORE — Gene and cell therapies have transformed a handful of devastating disorders in the U.S. and Europe, with more…
Read More » -
Cytokinetics pitches its heart drug
This is the online edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to get it…
Read More » -
Lisata, Eisai x Biogen, and the Met Gala (!)
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your…
Read More » -
Crackdown on China pharma industry would threaten U.S. drug supply
U.S. legislation that would sever ties with Chinese drugmakers would jeopardize the drug supply for millions of American patients if…
Read More » -
Getting Alzheimer’s drug Leqembi to patients can be a challenge
A host of hurdles are slowing the adoption of the new Alzheimer’s drug Leqembi, experts involved in the treatment of…
Read More » -
Google says AlphaFold 3 can map a vast universe of biomolecules
Google on Wednesday unveiled an artificial intelligence tool capable of predicting the structure and interaction of a vast universe of…
Read More » -
Regeneron, Eli Lilly, Pfizer updates
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your…
Read More » -
Young boy dies in trial for Pfizer Duchenne gene therapy
A young boy died in a trial for Pfizer’s experimental gene therapy for Duchenne muscular dystrophy, the company told patient…
Read More »